the Proportion of patients with treatment has reached the stage of complete remission.

In the UK are clinically tested medications from melanoma, which used a modified herpes virus, - reports The Guardian with reference to Journal of Clinical Oncology.

In testing a new drug involved more than 400 patients with melanoma in inoperable stage, some metastases were already in the lungs and liver. Patients received a "virotherapy" - method of treatment in which one disease takes control over the other.

virus Particles of herpes. Photo: Bernhard Classen/Alamy

an Experimental drug was based on a genetically modified herpes virus. The modified virus does not affect healthy cells, at the same time, getting into cancer, it multiplies and produces naturally occurring in the human body is a protein that stimulates the immune system and allows the tumor to grow.

the Response to treatment was observed in one patient out of four, 16% passed the disease in remission after six months of treatment. About 10% of patients treated with the drug achieved "complete remission" and got rid of all the symptoms of melanoma.

"This method gives huge prospects", " says Kevin Harrington Kevin Harrington, Professor of biological cancer therapy at the Institute for the study of cancer cells at University College London, who led the work on a cure. - "This is the first large-scale study of virotherapy, which confirmed its therapeutic effect."

If the medicine is approved, it will be marketed under the name of T-VEC and, according to the researchers, will be widely available next year.

See also: Three stories about how to survive cancer and not be afraid to tell others about him